International Journal of Drug Policy
Volume 13, Issue 3 , Pages 149-164 , September 2002

The impact of an HIV prevention intervention for injecting drug users in Svetlogorsk, Belarus: model predictions

Received 11 January 2002 ,Accepted 1 April 2002.

References 

  1. Aral SO, Hughes JP, Stoner B, Whittington W, Handsfield HH, Anderson RM, et al. Sexual mixing patterns in the spread of gonococcal and chlamydial infections. American Journal of Public Health. 1999;89:825–833
  2. Ball AL, Rana S, Dehne KL. HIV prevention among injecting drug users: responses in developing and transitional countries. Public Health Reports. 1998;113(1):170–181
  3. Barlow D, Daker White G, Band B. Assortative sexual mixing in a heterosexual clinic population—a limiting factor in HIV spread?. AIDS. 1997;11:1039–1044
  4. Blower SM, Dowlatabadi H. Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example. International Statistics Review. 1994;62:229–243
  5. Bogard E, Kuntz KM. The impact of a partially effective HIV vaccine on a population of intravenous drug users in Bangkok, Thailand: a dynamic model. Journal of Acquired Immune Deficiency Syndromes. 2002;29:132–141
  6. Broadhead RS, Van Hulst Y, Heckathorn DD. The impact of a needle exchange's closure. Public Health Reports. 1999;114:439–447
  7. Brogly SB, Bruneau J, Vincelette J, Lamothe F, Franco EL. Risk behaviour change and HIV infection among injection drug users in Montreal. AIDS. 2000;14:2575–2582
  8. Burrows D, Trautmann F, Frost L, Bijl M, Sarankov Y, Sarang A, et al. Processes and outcomes of training on rapid assessment and response methods on injecting drug use and related HIV infection in the Russian Federation. International Journal of Drug Policy. 2000;11:151–167
  9. Davis KR, Weller SC. The effectiveness of condoms in reducing heterosexual transmission of HIV. Family Planning Perspectives. 1999;31:272–279
  10. Des Jarlais DC, Hagan H, Friedman SR, Friedman P, Goldberg D, Frischer M, et al. Preventing epidemics of HIV-1 among injecting drug users. In:  Stimson GV,  Des Jarlais DC,  Ball A editor. Drug injecting and HIV infection. London: UCL Press; 1998;
  11. Des Jarlais DC, Marmor M, Friedmann P, Titus S, Aviles E, Deren S, et al. HIV incidence among injection drug users in New York City, 1992–1997: evidence for a declining epidemic. American Journal of Public Health. 2000;90:352–359
  12. Donoghoe MC, Wodak A. Health and social consequences of injecting drug use. In:  Stimson GV,  Des Jarlais DC,  Ball A editor. Drug injecting and HIV infection. London: UCL Press; 1998;
  13. Donoghoe MC, Stimson GV, Dolan KA. Sexual behaviour of injecting drug users and associated risks of HIV infection for non-injecting sexual partners. AIDS Care. 1989;1:51–58
  14. Flynn N, Jain S, Keddie EM, Carlson JR, Jennings MB, Haverkos HW, et al. In vitro activity of readily available household materials against HIV-1: is bleach enough?. Journal of Acquired Immune Deficiency Syndromes. 1994;7:747–753
  15. Garnett GP, Hughes JP, Anderson RM, Stoner BP, Aral SO, Whittington WL, et al. Sexual mixing patterns of patients attending sexually transmitted diseases clinics. Sexually Transmitted Diseases. 1996;23:248–257
  16. Garnett GP, Aral SO, Hoyle DV, Cates W, Anderson RM. The natural history of syphilis. Implications for the transmission dynamics and control of infection. Sexually Transmitted Diseases. 1997;24:185–200
  17. Goedert JJ, Fung MW, Felton S, Battjes RJ, Engels EA. Cause-specific mortality associated with HIV and HTLV-II infections among injecting drug users in the USA. AIDS. 2001;15:1295–1302
  18. Gras MJ, Weide JF, Langendam MW, Coutinho RA, van den Hoek A. HIV prevalence, sexual risk behaviour and sexual mixing patterns among migrants in Amsterdam, The Netherlands. AIDS. 1999;13:1953–1962
  19. Hagan H, Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. American Journal of Public Health. 1995;85:1531–1537
  20. Hartgers C, Buning EC, van Santen GW, Verster AD, Coutinho RA. The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behaviour. AIDS. 1989;3:571–576
  21. Heimer, R. (1999). Effectiveness of cleaning syringes with water and bleach (personal communication to C.H. Watts), e-mail (13 December 1999).
  22. European Study Group on Heterosexual Transmission of HIV . Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ. 1992;304:809–813
  23. European Study Group on Heterosexual Transmission of HIV . Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. American Journal of Epidemiology. 1998;148:88–96
  24. Holmes KK, Johnson DW, Trostle HJ. An estimate of the risk of men acquiring gonorrhea by sexual contact with infected females. American Journal of Epidemiology. 1970;91:170–174
  25. Holtgrave DR, Pinkerton SD, Jones TS, Lurie P, Vlahov D. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;18(1):S133–S138
  26. Hudgens MG, Longini IM, Vanichseni S, Hu DH, Kitayaporn D, Mock PA, et al. Subtype-specific transmission probabilities for Human Immunodeficiency Virus among injecting drug users in Bangkok, Thailand. American Journal of Epidemiology. 2002;155:159–168
  27. Hunter GM, Donoghoe MC, Stimson GV, Rhodes T, Chalmers CP. Changes in the injecting risk behaviour of injecting drug users in London, 1990–1993. AIDS. 1995;9:493–501
  28. Jacobs P, Calder P, Taylor M, Houston S, Saunders LD, Albert T. Cost effectiveness of Streetworks' needle exchange program of Edmonton. Canadian Journal of Public Health. 1999;90:168–171
  29. Jones TS, Vlahov D. Use of sterile syringes and aseptic drug preparation are important components of HIV prevention among injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;18(1):S1–S5
  30. Kaplan EH, Heimer R. A model-based estimate of HIV infectivity via needle sharing. Journal of Acquired Immune Deficiency Syndromes. 1992;5:1116–1118
  31. Kaplan EH, Heimer R. A circulation theory of needle exchange [editorial]. AIDS. 1994;8:567–574
  32. Kaplan E, O'Keefe E. Let the needles do the talking! Evaluating the New Haven needle exchange. Interfaces. 1993;23:7–26
  33. Korenromp EL, Van Vliet C, Grosskurth H, Gavyole A, Van der Ploeg CP, Fransen L, et al. Model-based evaluation of single-round mass treatment of sexually transmitted diseases for HIV control in a rural African population. AIDS. 2000;14:573–593
  34. Kumar MS, Mudaliar S, Daniels D. Community-based outreach HIV intervention for street-recruited drug users in Madras, India. Public Health Reports. 1998;113(1):58–66
  35. Kumaranayake, L., & Walker, D. (1999). Costing guidelines for HIV/AIDS prevention strategies among injecting drug user populations. UNAIDS UNAIDS Best Practice Collection—Key Materials, p. 72.
  36. Lakhumalani, V. (1998). Report of workshop on prevention of HIV and AIDS in Belarus. Presented at Workshop on prevention of HIV and AIDS, Minsk.
  37. Laufer FN. Cost-effectiveness of syringe exchange as an HIV prevention strategy. Journal of Acquired Immune Deficiency Syndromes. 2001;28:273–278
  38. Louria DB, Skurnick JH, Palumbo P, Bogden JD, Rohowsky Kochan C, Denny TN, et al. HIV heterosexual transmission: a hypothesis about an additional potential determinant. International Journal of Infectious Diseases. 2000;4:110–116
  39. Lurie P, Gorsky R, Jones TS, Shomphe L. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;18(1):S126–S132
  40. McCoy CB, Metsch LR, Chitwood DD, Shapshak P, Comerford ST. Parenteral transmission of HIV among injection drug users: assessing the frequency of multiperson use of needles, syringes, cookers, cotton, and water. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;1:S25–S29
  41. Monterroso ER, Hamburger ME, Vlahov D, Des Jarlais DC, Ouellet LJ, Altice FL, et al. Prevention of HIV infection in street-recruited injection drug users. The collaborative injection drug user study (CIDUS). Journal of Acquired Immune Deficiency Syndromes. 2000;25:63–70
  42. Myer, L., Mathews, C., Little, F., & De Klock, A. (1999). The fate of condoms distributed to the public in South Africa: a national study investigating the use and waste of public sector condoms. University of Cape Town Department of Health Report, South Africa.
  43. Over M, Piot P. Human immunodeficiency virus infection and other sexually transmitted diseases in developing countries: public health importance and priorities for resource allocation. Journal of Infectious Diseases. 1996;174(2):S162–S175
  44. Peak A, Rana S, Maharjan SH, Jolley D, Crofts N. Declining risk for HIV among injecting drug users in Kathmandu, Nepal: the impact of a harm-reduction programme. AIDS. 1995;9:1067–1070
  45. Perucci CA, Arca M, Spadea T. A mathematical model to evaluate the impact of a multiple-strategy preventive prgramme on HIV Infection. In:  Paccaud F,  Vader JP,  Gutzwiller F editor. Assessing AIDS prevention. Basel: Birkhauser; 1992; (Selected papers presented at the international conference held in Montreux, Switzerland, October 29–November 1, 1990)
  46. Pinkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission. Social Science & Medicine. 1997;44:1303–1312
  47. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai project study group. The New England Journal of Medicine. 2000;342:921–929
  48. Rehle TM, Saidel TJ, Hassig SE, Bouey PD, Gaillard EM, Sokal DC. AVERT: a user-friendly model to estimate the impact of HIV/sexually transmitted disease prevention interventions on HIV transmission. AIDS. 1998;12(2):S27–S35
  49. Rhodes T, Ball A, Stimson GV, Kobyshcha Y, Fitch C, Pokrovsky V, et al. HIV infection associated with drug injecting in the newly independent states, eastern Europe: the social and economic context of epidemics. Addiction. 1999;94:1323–1336
  50. Royce RA, Sena A, Cates W, Cohen MS. Sexual transmission of HIV. The New England Journal of Medicine. 1997;336:1072–1078 [published erratum appears in The New England Journal of Medicine 1997, 337(Suppl. 11) 799]
  51. Safaeian M, Brookmeyer R, Vlahov D, Latkin C, Marx M, Strathdee S. Validity of self-reported needle exchange attendance among injection drug users: implications for program evaluation. American Journal of Epidemiology. 2002;155:169–175
  52. Schechter MT, Strathdee SA, Cornelisse PG, Currie S, Patrick DM, Rekart ML, et al. Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. AIDS. 1999;13:F45–F51
  53. Sears C, Guydish J, Weltzien EK, Lum PJ. Investigation of a secondary syringe exchange program for homeless young adult injection drug users in San Francisco, California, USA. Journal of Acquired Immune Deficiency Syndromes. 2001;27:193–201
  54. Seitz ST, Mueller GE. Viral load and sexual risk. In:  Kaplan E,  Brandeau ML editor. Modelling the AIDS epidemic: planning, policy and prediction. New York: Raven Press; 1994;
  55. Shapshak P, McCoy CB, Shah SM, Page JB, Rivers JE, Weatherby NL, et al. Preliminary laboratory studies of inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach. Journal of Acquired Immune Deficiency Syndromes. 1994;7:754–759
  56. Stimson GV, Choopanya K. Global perspectives on drug injecting. In:  Stimson GV,  Des Jarlais DC,  Ball A editor. Drug injecting and HIV infection. London: UCL Press; 1998;
  57. Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11:F59–F65
  58. Strathdee SA, van Ameijden EJ, Mesquita F, Wodak A, Rana S, Vlahov D. Can HIV epidemics among injection drug users be prevented?. AIDS. 1998;12 (Suppl. A):S71–S79
  59. Sweat M, Gregorich S, Sangiwa G, Furlonge C, Balmer D, Kamenga C, et al. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet. 2000;356:113–121
  60. UNAIDS (1998). HIV infection in eastern Europe. UNAIDS Press Release, 5.
  61. UNAIDS (2001). AIDS epidemic update. 1–21.
  62. van Ameijden EJ, Coutinho RA. Maximum impact of HIV prevention measures targeted at injecting drug users. AIDS. 1998;12:625–633
  63. Vanichseni S, Kitayaporn D, Mastro TD, Mock PA, Raktham S, Des Jarlais DC, et al. Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand. AIDS. 2001;15:397–405
  64. Vickerman, P. (2001). Modelling the impact of interventions focused upon different stages of a HIV epidemic amongst a population of intravenous drug users. Presented at 12th International Conference on the Reduction of Drug Related Harm, New Delhi, India, 2001.
  65. Weinstein MC, Graham JD, Siegel JE, Fineberg HV. Cost-effectiveness analysis of AIDS prevention programs: concepts, complications and illustrations. In:  Turner CF,  Miller HG,  Moses LE editor. Confronting AIDS: sexual behaviour and intravenous drug use. Washington, DC: National Academy Press; 1989;

PII: S0955-3959(02)00071-3

doi: 10.1016/S0955-3959(02)00071-3

International Journal of Drug Policy
Volume 13, Issue 3 , Pages 149-164 , September 2002

Article Tools

* Image Usage & Resolution